| 28 Aug, 09:43 am | — | … | Lupin Limited has informed the Exchange about ESG Rating by Crisil ESG Ratings and Analytics Ltd. | nse |
| 28 Aug, 09:41 am | — | … | Lupin Ltd - 500257 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- ESG Rating | bse |
| 24 Aug, 06:53 pm | — | … | Lupin Ltd - 500257 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating | bse |
| 24 Aug, 06:45 pm | — | … | Lupin Limited has informed the Exchange about ESG Rating by ESG Risk Assessments and Insights Limited. | nse |
| 20 Aug, 10:46 am | — | … | Lupin Limited has informed the Exchange about VISUfarma B.V., the Netherlands, a wholly owned subsidiary of the Company, has entered into an Exclusive License Agreement with Visus Therapeutics, Inc. U.S.A. | nse |
| 18 Aug, 10:10 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Demise | bse |
| 18 Aug, 10:04 pm | — | … | Lupin Limited has informed the Exchange regarding Demise of Dr. Sofia Mumtaz, President, Legal & Compliance, Canada, ANZ & NEA Business, a Senior Management Personnel of the Company. | nse |
| 17 Aug, 12:21 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Aug, 12:19 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated August 17, 2026, titled "Lupin Announces Approval from U.S. FDA for Pitolisant Tablets". | nse |
| 12 Aug, 05:47 pm | — | … | Lupin Limited has informed the Exchange about Transcript of Q1 FY2027 Earnings Conference Call | nse |
| 12 Aug, 05:43 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 10 Aug, 06:02 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Aug, 05:59 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated August 10, 2026, titled "Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspensionin the United States ". | nse |
| 10 Aug, 04:15 pm | — | … | Lupin Limited has informed the Exchange about Schedule of Institutional Investors Meets. | nse |
| 08 Aug, 12:15 pm | — | … | Lupin Limited has informed the Exchange regarding copies of Newspaper Publication regarding Unaudited Financial Results of the Company for the quarter ended June 30, 2026. | nse |
| 07 Aug, 09:36 pm | — | … | Lupin Limited has informed the Exchange about Link of Audio recording of the Earnings Call-Q1 FY27. | nse |
| 07 Aug, 09:30 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 07 Aug, 01:18 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 07 Aug, 01:13 am | — | … | Lupin Limited has informed the Exchange about Investor Presentation | nse |
| 06 Aug, 10:14 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 06 Aug, 10:12 pm | — | … | Lupin Limited has informed the Exchange about Investor Presentation | nse |
| 06 Aug, 10:08 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Aug, 10:04 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated August 06, 2026, titled "Lupin Q1 FY2027 Results ". | nse |
| 06 Aug, 10:02 pm | — | … | Lupin Ltd - 500257 - Board Meeting Outcome For Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026. | bse |
| 06 Aug, 09:53 pm | — | … | Lupin Limited has submitted to the Exchange, Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. | nse |
| 31 Jul, 05:08 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Lupin Announces the Approval of Diazepam Injection, USP in the United States". | nse |
| 31 Jul, 05:06 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 31 Jul, 11:16 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 31 Jul, 11:14 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection". | nse |
| 22 Jul, 06:43 pm | — | … | Lupin Limited has informed the Exchange about Schedule of Earnings Call for Q1 FY27. | nse |
| 22 Jul, 04:35 pm | — | … | Lupin Ltd - 500257 - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026. | bse |
| 21 Jul, 07:23 am | — | … | Lupin Limited has informed the Exchange about Lupin Inc. U.S.A., wholly owned subsidiary of the Company has entered into a licensing agreement in exchange of 332,000 Common Shares of Kaveri Therapeutics, Inc. U.S.A. | nse |
| 21 Jul, 07:13 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 14 Jul, 09:29 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated July 14, 2026, titled "Lupin Recognized Among India s Best Employers in the Nation-Builders Category by Great Place To Work® India 2026 ". | nse |
| 14 Jul, 09:27 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Jul, 08:45 pm | — | … | Lupin Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report of the Company for FY 2025-26'. | nse |
| 13 Jul, 08:00 pm | — | … | Lupin Ltd - 500257 - Reg. 34 (1) Annual Report. | bse |
| 08 Jul, 04:51 pm | — | … | Lupin Ltd - 500257 - Intimation Of Record Date For Payment Of Final Dividend. | bse |
| 08 Jul, 04:39 pm | — | … | Lupin Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Jul-2026. | nse |
| 08 Jul, 04:36 pm | — | … | Lupin Limited has informed the Exchange regarding Intimation of the Forty-Fourth Annual General Meeting to be held on Tuesday, August 04, 2026, at 04.00 p.m. (IST) through Video Conferencing/ Other Audio Visual Means. | nse |
| 06 Jul, 10:16 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Jul, 10:13 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated July 06, 2026, titled "Lupin Named Among World s Most Sustainable Companies by TIME and Statista". | nse |
| 01 Jul, 09:55 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 01 Jul, 09:53 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated July 01, 2026, titled "Lupin Receives EIR from U.S. FDA for its Somerset Facility with VAI Classification". | nse |
| 01 Jul, 06:22 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 01 Jul, 06:18 pm | — | … | Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc. (MPPI), a subsidiary company and Buyback of shares by MPPI. | nse |
| 01 Jul, 04:47 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 01 Jul, 04:44 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated July 01, 2026, titled "Lupin Announces EMA Approval for NaMuscla® Expansion for Pediatric Indicationwith New Strengths". | nse |
| 26 Jun, 09:38 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets". | nse |
| 26 Jun, 09:37 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |